Submission of voting Results and Scrutinizer''s Report.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Astal Laboratories held its 32nd AGM on September 12, 2025 via video conferencing. All seven resolutions were passed, with 58.35% of outstanding shares (5,736,089 out of 9,830,070) participating in voting. Promoters voted 100% in favor on every resolution (1,959,284 shares), while public non-institutional shareholders showed 97.81% support on most resolutions and 96.67% on the director re-appointment. The three ordinary resolutions covered adoption of FY25 audited financials, re-appointment of Ms. Ravikanti Shailaja (Non-Executive Director), and appointment of M/s. Mahendra Khandelwal & Co. as Secretarial Auditors. The four special resolutions approved expanding the company's borrowing limit under Section 180(1)(c), creation of mortgage/charge on assets under Section 180(1)(a), authority for investments/loans/guarantees under Section 186, and related-party transactions under Section 185.
This is a routine AGM outcome with strong shareholder approval across all items, so no immediate price catalyst is expected. However, the four special resolutions materially expand the company's financial flexibility — giving the board wider authority to borrow, pledge assets, and make investments or related-party transactions — which shareholders should monitor going forward.